WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced today new preliminary safety and […]

VIENNA, Austria–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from two studies evaluating the safety and efficacy of investigational uses of sofosbuvir-based regimens in chronic hepatitis C virus (HCV)-infected […]

Data Presentations at 2015 ECCMID Conference Highlight Key Findings in Light of the Growing Global Threat of Antibiotic Resistance GEORGE TOWN, GRAND CAYMAN–(Marketwired – Apr 24, 2015) – Theravance Biopharma, […]

In a fascinating and scorching editorial in the British Journal of Sports Medicine, three authors argue that the myth that exercise is the key to weight loss – and to […]

SALT LAKE CITY–(BUSINESS WIRE)–Tolero Pharmaceuticals, Inc, today announced that it presented nonclinical study results demonstrating profound synergy of lead candidate, alvocidib, and bromo and extra terminal (BET) protein inhibitors in acute myeloid […]

Bet you did not know that today is National DNA Day. It is. But before we all begin to party over our biological programming, remember this is also the day […]

Philadelphia – WEBWIRE – Friday, April 24, 2015 A team of Mayo Clinic researchers has succeeded in identifying the source of cancer in patients’ gastrointestinal tracts by analyzing DNA markers […]

SAN DIEGO, CA–(Marketwired – April 23, 2015) – Targazyme, Inc., announced today that the U.S. Food and Drug Administration (FDA) and Targazyme have reached concurrence on the company’s Special Protocol […]

NEWARK, CA–(Marketwired – April 23, 2015) – CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, today announced the […]

PHOENIX, AZ–(Marketwired – Apr 23, 2015) – Insys Therapeutics, Inc. (NASDAQ: INSY) (“Insys” or “the Company”) today announced that it has commenced dosing of pediatric epilepsy patients in a Phase […]